Portfolio 2 Investments
NUCLIDIUM AG
radiopharmaceuticals, biotechnology, oncology
series-b
€26 M
May 2026
Investor
Bionyra Pharma
biopharmaceuticals, biotechnology, healthcare
series-a
$165 M
Jun 2026
Investor